Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings Stock Forecast

Stock Price Forecast

The 18 analysts that cover Zimmer Biomet Holdings stock have a consensus rating of "Hold" and an average price target of $112.33, which forecasts a 21.57% increase in the stock price over the next year. The lowest target is $95 and the highest is $140.

Price Target: $112.33 (+21.57%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$95	$112.33	$112	$140
Change	+2.81%	+21.57%	+21.21%	+51.52%

Analyst Ratings

The average analyst rating for Zimmer Biomet Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	3	3	3	3	3	2
Buy	6	6	6	7	7	7
Hold	12	12	12	11	11	9
Sell	1	1	1	1	1	1
Strong Sell	1	1	1	1	1	1
Total	23	23	23	23	23	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Vijay Kumar Evercore ISI Group	Evercore ISI Group	Hold Maintains $102 → $96	Hold	Maintains	$102 → $96	+3.90%	Jul 8, 2025
William Plovanic Canaccord Genuity	Canaccord Genuity	Hold Maintains $115 → $101	Hold	Maintains	$115 → $101	+9.31%	May 12, 2025
David Turkaly JMP Securities	JMP Securities	Buy Maintains $140 → $125	Buy	Maintains	$140 → $125	+35.28%	May 7, 2025
David Roman Goldman Sachs	Goldman Sachs	Hold Maintains $120 → $104	Hold	Maintains	$120 → $104	+12.55%	May 6, 2025
Jayson Bedford Raymond James	Raymond James	Buy Maintains $119 → $104	Buy	Maintains	$119 → $104	+12.55%	May 6, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

8.27B

Increased by 7.64%

from 7.68B

Revenue Next Year

8.73B

Increased by 5.64%

from 8.27B

EPS This Year

8.05

Increased by 81.68%

from 4.43

EPS Next Year

8.40

Increased by 4.35%

from 8.05

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	6.13B	6.83B	6.94B	7.39B	7.68B	8.27B	8.73B	9.12B
Revenue Growth	-23.24%	11.42%	1.65%	6.55%	3.85%	7.64%	5.64%	4.50%
EPS	-0.67	1.91	1.10	4.88	4.43	8.05	8.40	9.22
EPS Growth	-	-	-42.50%	343.48%	-9.22%	81.68%	4.35%	9.82%
Forward PE	-	-	-	-	-	11.48	11.00	10.02
No. Analysts	-	-	-	-	-	32	31	20

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	8.6B	9.2B	9.7B
Avg	8.3B	8.7B	9.1B
Low	8.0B	8.3B	8.6B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.6%	11.4%	11.6%
Avg	7.6%	5.6%	4.5%
Low	3.7%	0.3%	-1.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	8.51	9.20	10.43
Avg	8.05	8.40	9.22
Low	7.74	7.67	8.39

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	92.0%	14.3%	24.2%
Avg	81.7%	4.3%	9.8%
Low	74.8%	-4.7%	-0.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.